Oral powder. White powder.
The product is indicated for the treatment of musculo-skeletal conditions where relief from pain and a reduction in the associated inflammation is required e.g. in lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation, particularly where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation. The product can be used as an anti-pyretic where this is considered advisable e.g. in viral respiratory infections.
Dosage and administration
For oral administration.
If no response is evident after 4-5 days, discontinue treatment. Hay may delay the absorption of phenylbutazone and so the onset of a clinical effect. It is advisable not to administer hay immediately prior to, or during the administration of the product. For ease of administration the product may be mixed with a limited quantity of bran or oats.
Not for use in horses intended for human consumption. Treated horses should never be slaughtered for human consumption. The horse must be declared as not intended for human consumption under national horse passport regulation.
Legal Category: POM-V
For further product information please click here. This link will take you to the Veterinary Medicines Directorate (VMD) website where you can search for the product and see the most up to date Summary of product characteristics (SPC)
For FEI Advice, click here.
All prices inclusive of VAT where applicable.